1-5 of 5
Yutaka Takeda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT218: Wilms′ tumor gene 1 (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer

Shigeo Koido, Sumiyuki Nishida, Sadamu Homma, Yutaka Takeda, Hideo Komita, Satoshi Morita, Toshinori Ito, Soyoko Morimoto, Yoshihiro Oka, Satoru Yanagisawa, Yoichi Toyama, Masahiro Ikegami, Hiroaki Nagano, Toshifumi Ohkusa, Hisao Tajiri, Haruo Sugiyama
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT218.
https://doi.org/10.1158/1538-7445.AM2014-CT218
Published: 01 October 2014
View article titled, Abstract CT218: Wilms′ tumor gene 1 (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer
Journal Articles

Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express α-Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer

Takashi Deguchi, Masahiro Tanemura, Eiji Miyoshi, Hiroaki Nagano, Tomohiko Machida, Yoshiaki Ohmura, Shogo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Yutaka Takeda, Toshinori Ito, Masaki Mori, Yuichiro Doki, Yoshiki Sawa
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5259–5269.
https://doi.org/10.1158/0008-5472.CAN-09-4313
Published: 30 June 2010
View article titled, Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express α-Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer
Open the PDF for Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express α-Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 4747: MUC1, remodeled to express α-gal epitopes immune-based therapy, can elicit both significant prolonged survival and effective antibody production against multiple tumor-associated antigens

Masahiro Tanemura, Takashi Deguchi, Eiji Miyoshi, Hiroaki Nagano, Syougo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Yutaka Takeda, Toshinori Ito, Masaki Mori, Yuichirou Doki
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4747.
https://doi.org/10.1158/1538-7445.AM10-4747
Published: 15 April 2010
View article titled, Abstract 4747: MUC1, remodeled to express α-gal epitopes immune-based therapy, can elicit both significant prolonged survival and effective antibody production against multiple tumor-associated antigens
Journal Articles

Abstract #356: Vaccination with increased immunogenicity of tumor antigen MUC1 engineered to express \#945;-gal epitopes elicited significant inhibition of tumor growth

Takashi Deguchi, Masahiro Tanemura, Eiji Miyoshi, Tomohiko Machida, Syougo Kobayashi, Shigeru Marubashi, Chunman Lee, Yutaka Takeda, Hiroaki Nagano, Yoshiki Sawa, Toshinori Ito, Masaki Mori, Yuichirou Doki
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 356.
Published: 01 May 2009
View article titled, Abstract #356: Vaccination with increased immunogenicity of tumor antigen MUC1 engineered to express \#945;-gal epitopes elicited significant inhibition of tumor growth
Journal Articles

Interferon alpha receptor-2c on cell membrane is important in antiproliferative effect of interferon-α against human hepatocellular carcinoma cells

Bazarragchaa Damdinsuren, Hiroaki Nagano, Masato Nakamura, Hiroshi Wada, Takehiro Noda, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Keizo Dono, Morito Monden
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1099.
Published: 15 April 2006
View article titled, Interferon alpha receptor-2c on cell membrane is important in antiproliferative effect of interferon-α against human hepatocellular carcinoma cells